Epigenetic Mechanisms Influencing Therapeutic Response in Breast Cancer

The majority of breast cancers are estrogen receptor (ER)+ and agents targeting the ER signaling pathway have markedly increased survival for women with breast cancer for decades. However, therapeutic resistance eventually emerges, especially in the metastatic setting. In the past decade disrupted e...

Descripción completa

Detalles Bibliográficos
Autores principales: Arruabarrena-Aristorena, Amaia, Toska, Eneda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239340/
https://www.ncbi.nlm.nih.gov/pubmed/35774123
http://dx.doi.org/10.3389/fonc.2022.924808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239340/
https://www.ncbi.nlm.nih.gov/pubmed/35774123
http://dx.doi.org/10.3389/fonc.2022.924808

Ejemplares similares